OBJECTIVE: In patients with major depressive disorder (MDD), enhanced activation of the rostral anterior cingulate cortex (rACC) during conflict resolution has been demonstrated with the use of functional magnetic resonance imaging (fMRI), which suggests dysregulation of the affective compartment of the ACC associated with error monitoring and cognitive control. Moreover, several previous studies have reported disrupted structural integrity in limbic brain areas and the orbitofrontal cortex in MDD. However, the relation between structural and functional alterations remains unclear. Therefore, the present study sought to investigate whether structural brain aberrations in terms of grey matter decreases directly in the medial frontal regions or in anatomically closely connected areas might be related to our previously reported functional alterations. METHODS: A sample of 16 female, drug-free patients with an acute episode of MDD and 16 healthy control subjects matched for age, sex and education were examined with structural high-resolution T(1)-weighted MRI; fMRI images were obtained in the same session. RESULTS: Voxel-based morphometry (VBM) revealed grey matter decreases in the orbitofrontal and subgenual cortex, in the hippocampus-amygdala complex and in the middle frontal gyrus. The relative hyperactivation of the rACC in terms of inability to deactivate this region during the Stroop Color-Word Test showed an inverse correlation with grey matter reduction in the orbitofrontal cortex. CONCLUSION: The present study provides strong evidence for an association between structural alterations in the orbitofrontal cortex and disturbed functional activation in the emotional compartment of the ACC in patients with MDD during cognitive control.
OBJECTIVE: In patients with major depressive disorder (MDD), enhanced activation of the rostral anterior cingulate cortex (rACC) during conflict resolution has been demonstrated with the use of functional magnetic resonance imaging (fMRI), which suggests dysregulation of the affective compartment of the ACC associated with error monitoring and cognitive control. Moreover, several previous studies have reported disrupted structural integrity in limbic brain areas and the orbitofrontal cortex in MDD. However, the relation between structural and functional alterations remains unclear. Therefore, the present study sought to investigate whether structural brain aberrations in terms of grey matter decreases directly in the medial frontal regions or in anatomically closely connected areas might be related to our previously reported functional alterations. METHODS: A sample of 16 female, drug-freepatients with an acute episode of MDD and 16 healthy control subjects matched for age, sex and education were examined with structural high-resolution T(1)-weighted MRI; fMRI images were obtained in the same session. RESULTS: Voxel-based morphometry (VBM) revealed grey matter decreases in the orbitofrontal and subgenual cortex, in the hippocampus-amygdala complex and in the middle frontal gyrus. The relative hyperactivation of the rACC in terms of inability to deactivate this region during the Stroop Color-Word Test showed an inverse correlation with grey matter reduction in the orbitofrontal cortex. CONCLUSION: The present study provides strong evidence for an association between structural alterations in the orbitofrontal cortex and disturbed functional activation in the emotional compartment of the ACC in patients with MDD during cognitive control.
Entities:
Keywords:
depression; depressive disorder; magnetic resonance imaging
Authors: E Mervaala; J Föhr; M Könönen; M Valkonen-Korhonen; P Vainio; K Partanen; J Partanen; J Tiihonen; H Viinamäki; A K Karjalainen; J Lehtonen Journal: Psychol Med Date: 2000-01 Impact factor: 7.723
Authors: Michael D Greicius; Benjamin H Flores; Vinod Menon; Gary H Glover; Hugh B Solvason; Heather Kenna; Allan L Reiss; Alan F Schatzberg Journal: Biol Psychiatry Date: 2007-01-08 Impact factor: 13.382
Authors: R Elliott; S C Baker; R D Rogers; D A O'Leary; E S Paykel; C D Frith; R J Dolan; B J Sahakian Journal: Psychol Med Date: 1997-07 Impact factor: 7.723
Authors: J Douglas Bremner; Meena Vythilingam; Eric Vermetten; Ahsan Nazeer; Jahangir Adil; Sarfraz Khan; Lawrence H Staib; Dennis S Charney Journal: Biol Psychiatry Date: 2002-02-15 Impact factor: 13.382
Authors: Giacomo Salvadore; Allison C Nugent; Herve Lemaitre; David A Luckenbaugh; Ruth Tinsley; Dara M Cannon; Alexander Neumeister; Carlos A Zarate; Wayne C Drevets Journal: Neuroimage Date: 2010-11-10 Impact factor: 6.556
Authors: Rebecca Kerestes; Zubin Bhagwagar; Pradeep J Nathan; Shashwath A Meda; Cecile D Ladouceur; Kathleen Maloney; David Matuskey; Barbara Ruf; Aybala Saricicek; Fei Wang; Godfrey D Pearlson; Mary L Phillips; Hilary P Blumberg Journal: Psychiatry Res Date: 2012-05-16 Impact factor: 3.222
Authors: Rajendra A Morey; Courtney C Haswell; Stephen R Hooper; Michael D De Bellis Journal: Neuropsychopharmacology Date: 2015-07-14 Impact factor: 7.853
Authors: Cynthia B da Silva; Clarissa L Yasuda; Anelyssa D'Abreu; Fernando Cendes; Iscia Lopes-Cendes; Marcondes C França Journal: Cerebellum Date: 2013-06 Impact factor: 3.847
Authors: Jaime S Ide; Sheng Zhang; Sien Hu; Rajita Sinha; Carolyn M Mazure; Chiang-Shan R Li Journal: Drug Alcohol Depend Date: 2013-09-17 Impact factor: 4.492